Current Report Filing (8-k)
June 07 2022 - 6:02AM
Edgar (US Regulatory)
0000350737
false
OCEAN BIO CHEM INC
0000350737
2022-06-03
2022-06-03
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 3, 2022
OCEAN
BIO-CHEM, INC.
(Exact name of registrant as specified in charter)
Florida |
|
0-11102 |
|
59-1564329 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer
Identification No.) |
4041 S.W. 47 Avenue, Fort Lauderdale, Florida |
|
33314 |
(Address of principal executive offices) |
|
(Zip Code) |
(954) 587-6280
(Registrant’s telephone number, including
area code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class |
|
Trading Symbol |
|
Name of each exchange on which registered |
Common Stock, $0.01 par value |
|
OBCI |
|
The NASDAQ Stock Market |
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company ☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders
Ocean Bio-Chem, Inc. (the “Company”) held its Annual Meeting
of Stockholders on June 3, 2022. The proposals submitted by the Board of Directors to a vote of the shareholders, and the results of the
voting on each proposal, are noted below.
Proposal No. 1 — Election of Directors.
The following nominees were elected by the shareholders to serve
on the Company’s Board of Directors until the next annual meeting of shareholders or until their respective successors have been
duly elected and qualified:
Nominees | |
For | | |
Withhold | | |
Non-Votes | |
Jeffrey S. Barocas | |
| 6,401,777 | | |
| 534,333 | | |
| 1,555,592 | |
Diana M. Conard | |
| 6,759,163 | | |
| 176,947 | | |
| 1,555,592 | |
Gregor M. Dornau | |
| 6,403,757 | | |
| 532,353 | | |
| 1,555,592 | |
Peter G. Dornau | |
| 6,409,729 | | |
| 526,381 | | |
| 1,555,592 | |
William W. Dudman | |
| 6,403,277 | | |
| 532,833 | | |
| 1,555,592 | |
James M. Kolisch | |
| 6,219,286 | | |
| 716,824 | | |
| 1,555,592 | |
Kimberly A. Krause | |
| 6,759,380 | | |
| 176,730 | | |
| 1,555,592 | |
John B. Turner | |
| 6,748,377 | | |
| 187,733 | | |
| 1,555,592 | |
Proposal No. 2 — Ratification of the Appointment of Independent
Registered Public Accounting Firm.
The shareholders ratified the appointment of Accell Audit & Compliance,
PA as the Company's independent registered public accounting firm for 2022. The voting results were as follows:
For | | |
Against | | |
Abstain | | |
Non-Votes | |
| | |
| | |
| | |
| |
| 8,488,168 | | |
| 2,800 | | |
| 734 | | |
| - | |
Proposal No. 3 — Advisory Vote on the Compensation of our
Named Executive Officers;
The shareholders approved, on an advisory basis, the compensation of
our named executive officers. The voting results were as follows.
For | | |
Against | | |
Abstain | | |
Non-Votes | |
| | |
| | |
| | |
| |
| 6,886,668 | | |
| 32,432 | | |
| 17,010 | | |
| 1,555,592 | |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
OCEAN BIO-CHEM, INC. |
|
|
|
Date: June 03, 2022 |
By: |
/s/ Jeffrey S. Barocas |
|
|
Jeffrey S. Barocas |
|
|
Chief Financial Officer |
2
Ocean Bio Chem (NASDAQ:OBCI)
Historical Stock Chart
From Apr 2024 to May 2024
Ocean Bio Chem (NASDAQ:OBCI)
Historical Stock Chart
From May 2023 to May 2024